There is increased risk for atrial fibrillation in patients with implanted devices exposed to hot outdoor temperatures.

Traditional cardiovascular risk assessment tools underperform among individuals with metabolic dysfunction-associated steatotic liver disease.

Early abdominal CT may be warranted among patients with unknown or uncertain biochemical screening results for primary aldosteronism.

MASLD rates have decreased, whereas liver fibrosis and cirrhosis rates have increased among US patients with type 2 diabetes since 2017.

GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...

LT4 plus L3 therapy vs LT4 therapy alone was associated with reduced mortality and dementia risks among patients with hypothyroidism.

The global prevalence of OA attributed to high BMI has steadily increased over the past 3 decades, particularly among women and in high-SDI regions.

There is decreased risk for CV events and mortality in patients with cardiac autonomic neuropathy that receive intensive glycemic treatment.

Diabetes remission was more likely and laparoscopic surgery was less likely among women than men with paragangliomas and pheochromocytomas.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Fluctuations in ovarian sex hormones across the menstrual cycle may influence women’s likelihood of alcohol consumption.

Tirzepatide use vs placebo was associated with slower decline in eGFR among patients with prediabetes and obesity or ...